Eight Pennsylvania cultivators approved to begin growing medical cannabis

Pennsylvania regulators have given the go-ahead to eight cultivators to begin growing medical marijuana, putting sales on track to begin in 2018. Once the product is ready, dispensaries should have plenty of customers to buy it, the Philadelphia Inquirer reported. The governor’s office said that more than 10,000 patients have signed up for the program,…

A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia

CBD improves cognition in multiple preclinical models of cognitive impairment, including models of neuropsychiatric (schizophrenia), neurodegenerative (Alzheimer’s disease), neuro-inflammatory (meningitis, sepsis and cerebral malaria) and neurological disorders (hepatic encephalopathy and brain ischemia). The efficacy of CBD to improve cognition in schizophrenia cannot be elucidated due to lack of clinical evidence; however, given the ability of CBD to restore cognition in multiple studies of impairment, further investigation into its efficacy in schizophrenia is warranted. Potential mechanisms underlying the efficacy of CBD to improve cognition are discussed.